Reappraisal of the Prostaglandin E1 Dose for Early Newborns with Patent Ductus Arteriosus-Dependent Pulmonary Circulation

Reappraisal of the Prostaglandin E1 Dose for Early Newborns with Patent Ductus Arteriosus-Dependent Pulmonary Circulation

The usual initial dose of prostaglandin E1 (PGE1) for ductal-dependent congenital heart disease (CHD) is 50–100 ng/kg/minute. The aim of this study was to review our experience of a low initial dose of PGE1 treatment in early newborns with congenital heart disease and patent ductus arteriosus (PDA)-...

Full description

Bibliographic Details
Main Authors: Fu-Kuei Huang, Chu-Chuan Lin, Ta-Cheng Huang, Ken-Pen Weng, Po-Yen Liu, Ying-Yao Chen, Hsiao-Ping Wang, Luo-Ping Ger, Kai-Sheng Hsieh
Format: Article
Language:English
Published: Elsevier 2013-04-01
Series:Pediatrics and Neonatology
Subjects:
congenital heart disease
patent ductus arteriosus
prostaglandin E1
Online Access:http://www.sciencedirect.com/science/article/pii/S1875957212001684

Internet

http://www.sciencedirect.com/science/article/pii/S1875957212001684

Similar Items